{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/948318065",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/1891241424"
  ],
  "child": [
    "http://id.who.int/icd/release/11/2024-01/mms/1135131524",
    "http://id.who.int/icd/release/11/2024-01/mms/2045972468",
    "http://id.who.int/icd/release/11/2024-01/mms/1898142711",
    "http://id.who.int/icd/release/11/2024-01/mms/724622780"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#948318065",
  "code": "",
  "source": "http://id.who.int/icd/entity/948318065",
  "classKind": "block",
  "foundationChildElsewhere": [
    {
      "label": {
        "@language": "en",
        "@value": "Bromocriptine"
      },
      "foundationReference": "http://id.who.int/icd/entity/1016305819",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/1016305819"
    }
  ],
  "title": {
    "@language": "en",
    "@value": "Prolactin inhibitors"
  }
}